Enantigen Therapeutics SBIR Phase I Award,
A SBIR Phase I contract was awarded to Enantigen Therapeutics for $282,480.0 USD from the U.S. Department of Health & Human Services.
Is a
Award Amount (USD)
282,480
SBIR/STTR Award Recipient
Contract Number (US Government)
1R43AI084267-01
Award Phase
Phase I
Award Type
SBIR
Official Website
Find more entities like Enantigen Therapeutics SBIR Phase I Award,
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.